Effects of small interfering RNA-mediated downregulation of the Krüppel-like factor 4 gene on collagen metabolism in human hepatic stellate cells

Li,Tao; Niu,Lijuan; Li,Man; Liu,Ying; Xu,Zhengrong; Gao,Xia; Liu,Dianwu

doi:10.3892/mmr.2015.3848

Effects of small interfering RNA-mediated downregulation of the Krüppel-like factor 4 gene on collagen metabolism in human hepatic stellate cells

Authors:
- Tao Li
- Lijuan Niu
- Man Li
- Ying Liu
- Zhengrong Xu
- Xia Gao
- Dianwu Liu
View Affiliations

Affiliations: Department of Epidemiology and Health Statistics, School of Public Health, Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China, Department of Oncology, The Third Hospital of Shijiazhuang, Shijiazhuang, Hebei 050000, P.R. China
Published online on: May 26, 2015 https://doi.org/10.3892/mmr.2015.3848
Pages: 3972-3978

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The nuclear transcription factor Krüppel-like factor 4 (KLF4) has an important role in cellular biological processes. However, the influence of KLF4 on collagen metabolism remains to be elucidated. In the present study, the effects and underlying mechanism of action of KLF4 on collagen metabolism was investigated in human hepatic stellate cells (HSC), by downregulating KLF4 expression using small interfering RNA (siRNA). The effects of KLF4 silencing by three predesigned siRNAs (siRNA1‑3) were evaluated using both reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) and western blotting in the human LX2 HSC line. The mRNA expression levels of KLF4 were decreased by ~34, 40, and 69% in the siRNA1, siRNA2, and siRNA3 groups, respectively, as compared with the control group. These results were concordant with the protein expression levels of KLF4, as determined by western blot analysis. In the siRNA3 group, the quantity of type Ⅰ and type III collagen, and the expression levels of collagen metabolism proteins including matrix metalloproteinase‑1 (MMP‑1) and tissue inhibitors of metalloproteinases‑1 (TIMP‑1), were determined using both RT‑qPCR and western blotting. Both the mRNA and protein expression levels of type I and type III collagen were significantly decreased in the siRNA3 group, as compared with the control group. The mRNA and protein expression levels of TIMP‑1 were also significantly reduced in the siRNA3‑treated cells, whereas the mRNA and protein expression levels of MMP‑1 were significantly upregulated. Furthermore, KLF4 gene silencing significantly decreased the expression levels of numerous cytokines, including transforming grow factor‑β1, tumor necrosis factor‑α, and interleukin‑1β. The results of the present study provide evidence of siRNA‑mediated silencing of KLF4 expression, which may promote extracellular matrix (ECM) degradation, and inhibition of ECM synthesis. Therefore, KLF4 may be a promising target for the development of novel antifibrotic therapies.

View Figures

View References

1	Friedman SL: Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem. 275:2247–2250. 2000. View Article : Google Scholar : PubMed/NCBI
2	Pinzani M, Romanelli RG and Magli S: Progression of fibrosis in chronic liver diseases: Time to tally the score. J Hepatol. 34:764–767. 2001. View Article : Google Scholar : PubMed/NCBI
3	Brenner DA, Waterboer T, Choi SK, et al: New aspects of hepatic fibrosis. J Hepatol. 32(Suppl 1): 32–38. 2000. View Article : Google Scholar : PubMed/NCBI
4	Schuppan D, Ruehl M, Somasundaram R and Hahn EG: Matrix as a modulator of hepatic fibrogenesis. Semin Liver Dis. 21:351–372. 2001. View Article : Google Scholar : PubMed/NCBI
5	Desmet VJ and Roskams T: Cirrhosis reversal: A duel between dogma and myth. J Hepatol. 40:860–867. 2004. View Article : Google Scholar : PubMed/NCBI
6	Gordillo-Bastidas D, Oceguera-Contreras E, Salazar-Montes A, González-Cuevas J, Hernández-Ortega LD and Armendáriz-Borunda J: Nrf2 and Snail-1 in the prevention of experimental liver fibrosis by caffeine. World J Gastroenterol. l9:9020–9033. 2013. View Article : Google Scholar
7	Hayden MS and Ghosh S: Signaling to NF-kappaB. Genes Dev. 18:2195–2224. 2004. View Article : Google Scholar : PubMed/NCBI
8	Cisneros L, Londoño MC, Blasco C, et al: Hepatic stellate cell activation in liver transplant patients with hepatitis C recurrence and in non-transplanted patients with chronic hepatitis C. Liver Transpl. 13:1017–1027. 2007. View Article : Google Scholar : PubMed/NCBI
9	Enami Y, Bandi S, Kapoor S, Krohn N, Joseph B and Gupta S: Hepatic stellate cells promote hepatocyte engraftment in rat liver after prostaglandin-endoperoxide synthase inhibition. Gastroenterology. 136:2356–2364. 2009. View Article : Google Scholar : PubMed/NCBI
10	Wells RG: Cellular sources of extracellular matrix in hepatic fibrosis. Clin Liver Dis. 12:759–768. 2008. View Article : Google Scholar : PubMed/NCBI
11	Pellicoro A, Ramachandran P and Iredale JP: Reversibility of liver fibrosis. Fibrogenesis Tissue Repair 5 (Suppl 1 Proceedings of Fibroproliferative disorders: From biochemical analysis to targeted therapies Petro E Petrides and David Brenner). S262012.
12	Kim JB, Ann YH, Park SY, et al: Side population in LX2 cells decreased by transforming growth factor-β. Hepatol Res. 44:229–237. 2014. View Article : Google Scholar
13	Brenner DA: Molecular pathogenesis of liver fibrosis. Trans Am Clin Climatol Assoc. 120:361–368. 2009.PubMed/NCBI
14	Bieker JJ: Krüppel-like factors: Three fingers in many pies. J Biol Chem. 276:34355–34358. 2001. View Article : Google Scholar : PubMed/NCBI
15	Turner J and Crossley M: Mammalian Krüppel-like transcription factors: More than just a pretty finger. Trends Biochem Sci. 24:236–240. 1999. View Article : Google Scholar : PubMed/NCBI
16	Ghaleb AM, Nandan MO, Chanchevalap S, Dalton WB, Hisamuddin IM and Yang VW: Krüppel-like factors 4 and 5: The yin and yang regulators of cellular proliferation. Cell Res. 15:92–96. 2005. View Article : Google Scholar : PubMed/NCBI
17	Liu Y, Zhao J, Liu J, Zhang H, Liu M and Xiao X: Upregulation of the constitutively expressed HSC70 by KLF4. Cell Stress Chaperones. 13:337–345. 2008. View Article : Google Scholar : PubMed/NCBI
18	Fisch S, Gray S, Heymans S, et al: Kruppel-like factor 15 is a regulator of cardiomyocyte hypertrophy. Proc Natl Acad Sci USA. 104:7074–7079. 2007. View Article : Google Scholar : PubMed/NCBI
19	Wang B, Haldar SM, Lu Y, et al: The Kruppel-like factor KLF15 inhibits connective tissue growth factor (CTGF) expression in cardiac fibroblasts. J Mol Cell Cardiol. 45:193–197. 2008. View Article : Google Scholar : PubMed/NCBI
20	Haldar SM, Ibrahim OA and Jain MK: Kruppel-like Factors (KLFs) in muscle biology. J Mol Cell Cardiol. 43:1–10. 2007. View Article : Google Scholar : PubMed/NCBI
21	Shindo T, Manabe I, Fukushima Y, et al: Krüppel-like zinc-finger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling. Nat Med. 8:856–863. 2002.PubMed/NCBI
22	Yet SF, McA'Nulty MM, Folta SC, et al: Human EZF, a Krüppel-like zinc finger protein, is expressed in vascular endothelial cells and contains transcriptional activation and repression domains. J Biol Chem. 273:1026–1031. 1998. View Article : Google Scholar : PubMed/NCBI
23	Chen X, Johns DC, Geiman DE, et al: Krüppel-like factor 4 (gut-enriched Krüppel-like factor) inhibits cell proliferation by blocking G1/S progression of the cell cycle. J Biol Chem. 276:30423–30428. 2001. View Article : Google Scholar : PubMed/NCBI
24	Chen X, Whitney EM, Gao SY and Yang VW: Transcriptional profiling of Krüppel-like factor 4 reveals a function in cell cycle regulation and epithelial differentiation. J Mol Biol. 326:665–677. 2003. View Article : Google Scholar : PubMed/NCBI
25	Wang C, Han M, Zhao XM and Wen JK: Kruppel-like factor 4 is required for the expression of vascular smooth muscle cell differentiation marker genes induced by all trans-retinoic acid. J Biochem. 144:313–321. 2008. View Article : Google Scholar : PubMed/NCBI
26	Zhang Y, Wang Y, Liu Y, Wang N, Qi Y and Du J: Krüppel-like factor 4 transcriptionally regulates TGF-β1 and contributes to cardiac myofibroblast differentiation. PLoS One. 8:e634242013. View Article : Google Scholar
27	Levenkova N, Gu Q and Rux JJ: Gene specific siRNA selector. Bioinformatics. 20:430–432. 2004. View Article : Google Scholar : PubMed/NCBI
28	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar
29	Bustin SA: Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol. 25:169–193. 2000. View Article : Google Scholar : PubMed/NCBI
30	Yoshinari K, Miyagishi M and Taira K: Effects on RNAi of the tight structure, sequence and position of the targeted region. Nucleic Acids Res. 32:691–699. 2004. View Article : Google Scholar : PubMed/NCBI
31	Sciabola S, Cao Q, Orozco M, Faustino I and Stanton RV: Improved nucleic acid descriptors for siRNA efficacy prediction. Nucleic Acids Res. 41:1383–1394. 2013. View Article : Google Scholar :
32	Wang JY, Guo JS and Yang CQ: Expression of exogenous rat collagenase in vitro and in a rat model of liver fibrosis. World J Gastroenterol. 8:901–907. 2002.PubMed/NCBI
33	Dun ZN, Zhang XL, An JY, Zheng LB, Barrett R and Xie SR: Specific shRNA targeting of FAK influenced collagen metabolism in rat hepatic stellate cells. World J Gastroenterol. 16:4100–4106. 2010. View Article : Google Scholar : PubMed/NCBI
34	Moreira RK: Hepatic stellate cells and liver fibrosis. Arch Pathol Lab Med. 131:1728–1734. 2007.PubMed/NCBI
35	Consolo M, Amoroso A, Spandidos DA and Mazzarino MC: Matrix metalloproteinases and their inhibitors as markers of inflammation and fibrosis in chronic liver disease (Review). Int J Mol Med. 24:143–52. 2009.PubMed/NCBI
36	Milani S, Herbst H, Schuppan D, et al: Differential expression of matrix-metalloproteinase-1 and -2 genes in normal and fibrotic human liver. Am J Pathol. 144:528–537. 1994.PubMed/NCBI
37	Murawaki Y, Ikuta Y, Idobe Y and Kawasaki H: Serum matrix metalloproteinase-1 in patients with chronic viral hepatitis. J Gastroenterol Hepatol. 14:138–145. 1999. View Article : Google Scholar : PubMed/NCBI
38	Pardo A and Selman M: MMP-1: The elder of the family. Int J Biochem Cell Biol. 37:283–288. 2005. View Article : Google Scholar
39	Iimuro Y, Nishio T, Morimoto T, et al: Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat. Gastroenterology. 124:445–458. 2003. View Article : Google Scholar : PubMed/NCBI
40	Birkedal-Hansen H, Moore WG, Bodden MK, et al: Matrix metalloproteinases: A review. Crit Rev Oral Biol Med. 4:197–250. 1993.PubMed/NCBI
41	Xu GF, Li PT, Wang XY, et al: Dynamic changes in the expression of matrix metalloproteinases and their inhibitors, TIMPs, during hepatic fibrosis induced by alcohol in rats. World J Gastroenterol. 10:3621–3627. 2004.PubMed/NCBI
42	Wang CH, Lee TH, Lu CN, et al: Electroporative alpha-MSH gene transfer attenuates thioacetamide-induced murine hepatic fibrosis by MMP and TIMP modulation. Gene Ther. 13:1000–1009. 2006. View Article : Google Scholar : PubMed/NCBI
43	Inagaki Y and Okazaki I: Emerging insights into Transfo rming growth factor beta Smad signal in hepatic fibrogenesis. Gut. 56:284–292. 2007. View Article : Google Scholar : PubMed/NCBI
44	Zhou J, Zhong DW, Wang QW, Miao XY and Xu XD: Paclitaxel ameliorates fibrosis in hepatic stellate cells via inhibition of TGF-beta-Smad activity. World J Gastroenterol. 16:3330–3334. 2010. View Article : Google Scholar : PubMed/NCBI
45	Kondou H, Mushiake S, Etani Y, Miyoshi Y, Michigami T and Ozono K: A Blocking peptide for transforming growth factor-beta 1 activation prevents hepatic fibrosis in vivo. J Hepatol. 39:742–748. 2003. View Article : Google Scholar : PubMed/NCBI
46	Okuno M, Akita K, Moriwaki H, et al: Prevention of rat hepatic fibrosis by the protease inhibitor, camostat mesilate, via reduced generation of active TGF-beta. Gastroenterology. 120:1784–1800. 2001. View Article : Google Scholar : PubMed/NCBI
47	Marchetti L, Klein M, Schlett K, Pfizenmaier K and Eisel UL: Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl D-aspartate receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-kappa B pathway. J Biol Chem. 279:32869–32881. 2004. View Article : Google Scholar : PubMed/NCBI
48	Bortolami M, Kotsafti A, Cardin R and Farinati F: Fas/FasL system, IL-1beta expression and apoptosis in chronic HBV and HCV liver disease. J Viral Hepat. 15:515–522. 2008. View Article : Google Scholar : PubMed/NCBI
49	Saile B and Ramadori G: Inflammation, damage repair and liver fibrosis – role of cytokines and different cell types. Z Gastroenterol. 45:77–86. 2007. View Article : Google Scholar : PubMed/NCBI